Anti-TNF-α therapies have been applied to a variety of autoimmune disorders, such as rheumatoid arthritis [25], inflammatory bowel disease [26] and systemic lupus erythematosus [27]. This evidence concerns the gene TNF and systemic lupus erythematosus.